Literature DB >> 2335450

SWS (blue) cone hypersensitivity in a newly identified retinal degeneration.

S G Jacobson1, M F Marmor, C M Kemp, R W Knighton.   

Abstract

Photoreceptor-mediated mechanisms were studied in patients with a recently identified retinopathy typified by night blindness, cystoid maculopathy, and similar scotopic and photopic electroretinograms (ERGs). Dark-adapted spectral sensitivity functions were only partly explained as composites of rod and cone curves shifted to lower sensitivities; there was unusually high sensitivity from 400-460 nm. A rod mechanism, reduced in sensitivity by at least 3 log units, was detectable with dark adaptometry. No measurable rhodopsin was found with fundus reflectometry. Light-adapted spectral sensitivities were subnormal for wavelengths greater than 500 nm but supernormal from 420-460 nm. On a yellow adapting field, the supernormal spectrum approximated that of the short-wavelength-sensitive (SWS) cone system. With spectral ERGs, two mechanisms were demonstrated. Dark- and light-adapted ERGs to green, orange-yellow, and red stimuli had similar waveforms and coincident intensity-response functions on a photopic intensity axis. ERGs to blue and blue-green stimuli were similar, and intensity-response functions coincided on a SWS cone intensity axis. Patients varied in the degree to which rod and midspectral cone function were decreased and SWS cone function was increased.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335450

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  Electroretinographic evaluation of the retinal S-cone system.

Authors:  Maja Sustar; Marko Hawlina; Jelka Brecelj
Journal:  Doc Ophthalmol       Date:  2011-11-27       Impact factor: 2.379

2.  A novel mutation (Cys83Tyr) in the second zinc finger of NR2E3 in enhanced S-cone syndrome.

Authors:  Amândio Rocha-Sousa; Takaaki Hayashi; Nuno Lourenço Gomes; Susana Penas; Elisete Brandão; Paulo Rocha; Mitsuyoshi Urashima; Hisashi Yamada; Hiroshi Tsuneoka; Fernando Falcão-Reis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-20       Impact factor: 3.117

3.  A detailed phenotypic study of "cone dystrophy with supernormal rod ERG".

Authors:  M Michaelides; G E Holder; A R Webster; D M Hunt; A C Bird; F W Fitzke; J D Mollon; A T Moore
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

4.  Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.

Authors:  M Sustar; D Perovšek; I Cima; B Stirn-Kranjc; M Hawlina; J Brecelj
Journal:  Doc Ophthalmol       Date:  2015-02-07       Impact factor: 2.379

5.  Novel findings in enhanced S-cone syndrome: a case with macular retinal neovascularization and severe retinal vasculitis.

Authors:  Fatemeh Bazvand; Hasan Khojasteh; Mohammad Zarei
Journal:  Doc Ophthalmol       Date:  2019-07-10       Impact factor: 2.379

6.  Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function.

Authors:  Koji M Nishiguchi; James S Friedman; Michael A Sandberg; Anand Swaroop; Eliot L Berson; Thaddeus P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-09       Impact factor: 11.205

7.  Progressive cone dystrophy with deutan genotype and phenotype.

Authors:  Hendrik P N Scholl; Jan Kremers; Dorothea Besch; Eberhart Zrenner; Herbert Jägle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-05       Impact factor: 3.117

8.  New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.

Authors:  Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Sakuramoto; Hiroshi Mishima; Hiroshi Tsuneoka; Kazushige Tsunoda; Takeshi Iwata; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-08-13       Impact factor: 2.447

9.  Mapping of genetic modifiers of Nr2e3 rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity.

Authors:  Neena B Haider; Weidong Zhang; Ron Hurd; Akihiro Ikeda; Arne M Nystuen; Jürgen K Naggert; Patsy M Nishina
Journal:  Mamm Genome       Date:  2008-02-20       Impact factor: 2.957

10.  Mutations in the DNA-binding domain of NR2E3 affect in vivo dimerization and interaction with CRX.

Authors:  Raphael Roduit; Pascal Escher; Daniel F Schorderet
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.